Tyra Biosciences (TYRA) Short Interest Ratio & Short Volume $8.30 -0.35 (-4.05%) Closing price 04:00 PM EasternExtended Trading$8.29 -0.01 (-0.12%) As of 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Tyra Biosciences Short Interest DataTyra Biosciences (TYRA) has a short interest of 3.92 million shares, representing 12.23% of the float (the number of shares available for trading by the public). This marks a -3.92% decrease in short interest from the previous month. The short interest ratio (days to cover) is 14.1, indicating that it would take 14.1 days of the average trading volume of 296,266 shares to cover all short positions.Current Short Interest3,920,000 sharesPrevious Short Interest4,080,000 sharesChange Vs. Previous Month-3.92%Dollar Volume Sold Short$45.08 millionShort Interest Ratio14.1 Days to CoverLast Record DateMarch 15, 2025Outstanding Shares50,603,000 sharesFloat Size32,040,000 sharesShort Percent of Float12.23%Today's Trading Volume368,384 sharesAverage Trading Volume296,266 sharesToday's Volume Vs. Average124% Short Selling Tyra Biosciences? Sign up to receive the latest short interest report for Tyra Biosciences and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTYRA Short Interest Over TimeTYRA Days to Cover Over TimeTYRA Percentage of Float Shorted Over Time Remove Ads Tyra Biosciences Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 3/15/20253,920,000 shares $45.08 million -3.9%12.2%14.1 $11.50 2/28/20254,080,000 shares $47.78 million +10.9%12.7%15.7 $11.71 2/15/20253,680,000 shares $48.54 million +30.5%11.9%15.7 $13.19 1/31/20252,820,000 shares $40.78 million +1.8%9.2%11 $14.46 1/15/20252,770,000 shares $46.34 million +9.1%9.0%8 $16.73 12/31/20242,540,000 shares $35.31 million +0.4%8.3%7.4 $13.90 12/15/20242,530,000 shares $37.80 million +25.9%8.2%7.7 $14.94 11/30/20242,010,000 shares $31.52 million +7.5%6.8%6.1 $15.68 11/15/20241,870,000 shares $28.78 million +6.3%6.3%5.9 $15.39 10/31/20241,760,000 shares $29.36 million -20.0%6.1%6 $16.68 Get the Latest News and Ratings for TYRA and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Tyra Biosciences and its competitors with MarketBeat's FREE daily newsletter. 10/15/20242,200,000 shares $53.81 million -7.6%8.3%12 $24.46 9/30/20242,380,000 shares $55.95 million -0.8%8.9%15.4 $23.51 9/15/20242,400,000 shares $50.98 million +6.2%9.0%13.8 $21.24 8/31/20242,260,000 shares $51.44 million +2.3%8.5%13.8 $22.76 8/15/20242,210,000 shares $48.62 million -0.5%8.4%13 $22.00 7/31/20242,220,000 shares $49.20 million +0.5%8.3%13.5 $22.16 7/15/20242,210,000 shares $44.35 million +12.2%8.3%14.4 $20.07 6/30/20241,970,000 shares $31.50 million +3.8%7.4%12.6 $15.99 6/15/20241,897,500 shares $36.89 million -3.2%7.1%13.2 $19.44 5/31/20241,960,000 shares $31.79 million -4.4%7.4%13.2 $16.22 5/15/20242,050,000 shares $37.80 million -40.4%7.7%15.7 $18.44 4/30/20243,440,000 shares $58.82 million +5.2%11.0%26.5 $17.10 4/15/20243,270,000 shares $48.23 million +15.6%13.8%23.4 $14.75 3/31/20242,830,000 shares $46.41 million +8.9%14.9%21 $16.40 3/15/20242,600,000 shares $45.50 million +7.4%13.9%20.6 $17.50 2/29/20242,420,000 shares $48.38 million +6.6%13.0%21.4 $19.99 2/15/20242,270,000 shares $43.13 million +11.3%12.2%21.4 $19.00 1/31/20242,040,000 shares $27.34 million +8.5%10.8%20.4 $13.40 1/15/20241,880,000 shares $24.08 million +30.6%10.1%23.4 $12.81 12/31/20231,440,000 shares $19.94 million -7.1%N/A18.1 $13.85 12/15/20231,550,000 shares $20.93 million -7.2%8.4%20.1 $13.50 11/30/20231,670,000 shares $19.56 million +0.6%9.1%26.4 $11.71 11/15/20231,660,000 shares $20.53 million -6.7%9.0%26.9 $12.37 10/31/20231,780,000 shares $20.65 million +6.6%9.5%29.9 $11.60 10/15/20231,670,000 shares $23.61 million -6.2%8.9%30.5 $14.14 9/30/20231,780,000 shares $24.51 million -4.3%9.5%34.8 $13.77 9/15/20231,860,000 shares $27.36 million +3.3%9.9%29.3 $14.71 8/31/20231,800,000 shares $27.41 million +1.1%9.7%22.9 $15.23 8/15/20231,780,000 shares $27.59 million +6.0%9.6%22.7 $15.50 7/31/20231,680,000 shares $24.90 million +5.0%9.3%22.1 $14.82DOGE tax surprise (Ad)Elon Musk's DOGE agents have some very strange plans for the IRS... Recently, it emerged that our tax authorities have bought a powerful new AI supercomputer, worth millions of dollars. It's the most advanced technology offered by AI giant Nvidia. And it's almost certainly going to be used to advance Elon Musk's real agenda with DOGE... the massive, rapid roll out of AI across the entire federal government.Move now and you could get in first - with huge upside potential. 7/15/20231,600,000 shares $23.39 million +1.3%8.9%22.4 $14.62 6/30/20231,580,000 shares $26.91 million +9.0%8.8%23.8 $17.03 6/15/20231,450,000 shares $23.20 million -1.4%8.1%28 $16.00 5/31/20231,470,000 shares $21.27 million +2.8%8.3%47 $14.47 5/15/20231,430,000 shares $18.85 million -0.7%8.0%41.7 $13.18 4/30/20231,440,000 shares $20.40 million +0.7%8.0%28.4 $14.17 4/15/20231,430,000 shares $21.08 million +3.6%8.0%27.1 $14.74 3/31/20231,380,000 shares $22.18 million +7.0%7.8%26.1 $16.07 3/15/20231,290,000 shares $18.33 million +6.6%6.6%25.3 $14.21 2/28/20231,210,000 shares $15.98 million No Change6.2%24.2 $13.21 2/15/20231,210,000 shares $15.10 million -0.8%6.2%21.5 $12.48 1/31/20231,220,000 shares $12.96 million No Change6.2%26.9 $10.62 1/15/20231,220,000 shares $10.24 million -3.9%6.2%26.6 $8.39 12/30/20221,270,000 shares $9.65 million -14.8%6.5%26.5 $7.60 12/15/20221,490,000 shares $9.42 million -2.6%7.6%28.8 $6.32 11/30/20221,530,000 shares $10.73 million -1.3%7.9%31 $7.01 11/15/20221,550,000 shares $11.61 million -6.1%8.0%29.1 $7.49 10/31/20221,650,000 shares $11.42 million -2.4%8.5%39 $6.92 10/15/20221,690,000 shares $11.37 million -2.3%8.8%43.1 $6.73 9/30/20221,730,000 shares $15.21 million +1.2%9.0%41.7 $8.79 9/15/20221,710,000 shares $15.41 million -0.6%8.9%33.8 $9.01 8/31/20221,720,000 shares $11.37 million -8.5%8.9%32.3 $6.61 8/15/20221,880,000 shares $22.47 million -1.6%9.7%33.4 $11.95 7/31/20221,910,000 shares $20.34 million No Change9.8%32.8 $10.65 7/15/20221,910,000 shares $18.43 million -1.6%9.8%29.6 $9.65 6/30/20221,940,000 shares $13.87 million -1.0%10.0%28.9 $7.15 6/15/20221,960,000 shares $11.52 million +1.6%10.1%28.1 $5.88 5/31/20221,930,000 shares $13.18 million -2.5%9.9%23.1 $6.83 5/15/20221,980,000 shares $15.33 million -4.8%10.2%21.2 $7.74 4/30/20222,080,000 shares $15.54 million -8.0%10.6%21.1 $7.47 4/15/20222,260,000 shares $22.33 million -0.9%11.6%20.7 $9.88 3/31/20222,280,000 shares $24.40 million -2.6%11.8%19.8 $10.70 3/15/20222,340,000 shares $23.47 million +15.8%12.2%16.8 $10.03 2/28/20222,020,000 shares $23.94 million +6.3%10.5%10.6 $11.85 2/15/20221,900,000 shares $23.88 million -2.1%9.9%9.8 $12.57 1/31/20221,940,000 shares $25.43 million +7.2%10.3%9.9 $13.11 1/15/20221,810,000 shares $22.55 million +5.2%9.6%9 $12.46 12/31/20211,720,000 shares $24.20 million No Change9.1%8.3 $14.07 TYRA Short Interest - Frequently Asked Questions What is Tyra Biosciences' current short interest? Short interest is the volume of Tyra Biosciences shares that have been sold short but have not yet been covered or closed out. As of March 15th, investors have sold 3,920,000 shares of TYRA short. 12.23% of Tyra Biosciences' shares are currently sold short. Learn More on Tyra Biosciences' current short interest. What is a good short interest ratio for Tyra Biosciences? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TYRA shares currently have a short interest ratio of 14.0. Learn More on Tyra Biosciences's short interest ratio. Which institutional investors are shorting Tyra Biosciences? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Tyra Biosciences: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Tyra Biosciences? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.23% of Tyra Biosciences' floating shares are currently sold short. Is Tyra Biosciences' short interest increasing or decreasing? Tyra Biosciences saw a drop in short interest during the month of March. As of March 15th, there was short interest totaling 3,920,000 shares, a drop of 3.9% from the previous total of 4,080,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Tyra Biosciences' float size? Tyra Biosciences currently has issued a total of 50,603,000 shares. Some of Tyra Biosciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Tyra Biosciences currently has a public float of 32,040,000 shares. How does Tyra Biosciences' short interest compare to its competitors? 12.23% of Tyra Biosciences' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Tyra Biosciences: Denali Therapeutics Inc. (8.36%), Belite Bio, Inc (0.32%), Arrowhead Pharmaceuticals, Inc. (8.65%), Arcutis Biotherapeutics, Inc. (14.26%), Tarsus Pharmaceuticals, Inc. (21.10%), Harmony Biosciences Holdings, Inc. (9.45%), Travere Therapeutics, Inc. (14.90%), Janux Therapeutics, Inc. (21.18%), Disc Medicine, Inc. (10.29%), Agios Pharmaceuticals, Inc. (6.16%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($26.28 billion), iShares 20+ Year Treasury Bond ETF ($9.53 billion), MicroStrategy Incorporated ($8.50 billion), Apollo Global Management, Inc. ($4.86 billion), Super Micro Computer, Inc. ($4.85 billion), Charter Communications, Inc. ($4.28 billion), Capital One Financial Co. ($4.08 billion), AppLovin Co. ($3.82 billion), Canadian Natural Resources Limited ($3.78 billion), and Schlumberger Limited ($2.87 billion). View all of the most shorted stocks. What does it mean to sell short Tyra Biosciences stock? Short selling TYRA is an investing strategy that aims to generate trading profit from Tyra Biosciences as its price is falling. TYRA shares are trading down $0.07 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Tyra Biosciences? A short squeeze for Tyra Biosciences occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TYRA, which in turn drives the price of the stock up even further. How often is Tyra Biosciences' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TYRA, twice per month. The most recent reporting period available is March, 15 2025. More Short Interest Resources from MarketBeat Related Companies Denali Therapeutics Short Interest Belite Bio Short Interest Arrowhead Pharmaceuticals Short Interest Arcutis Biotherapeutics Short Interest Tarsus Pharmaceuticals Short Interest Harmony Biosciences Short Interest Travere Therapeutics Short Interest Janux Therapeutics Short Interest Disc Medicine Short Interest Agios Pharmaceuticals Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:TYRA) was last updated on 4/3/2025 by MarketBeat.com Staff From Our PartnersTrump’s Final Plan Presidential insider exposes shocking plot to reshape U.S. economy: The 2025 Trump Reset -- Inside Trump’...Porter & Company | SponsoredAmerica’s Retirement Accounts Are at Risk—Here’s WhyWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | SponsoredElon Musk Confirms: Tesla’s Optimus is Replacing Workers… and Heading to MarsMusk confirmed that SpaceX's Starship will carry Optimus to Mars in 2026 as part of an autonomous mission to h...InvestorPlace | SponsoredCaught on Camera: Elon Musk’s “Area 51”You won’t believe what tech legend Jeff Brown found in what he calls Elon Musk’s “Area 51.” (Click here to see...Brownstone Research | SponsoredRetirement Nightmare? It’s Already Happening.The market is on edge. Every day, another company slashes its dividend, leaving investors scrambling. Intel...Investors Alley | SponsoredWhy Elon Musk Is Investigating Fort KnoxWith gold prices recently soaring to record highs over $3,000 an ounce, and central banks rushing to accumulat...The Oxford Club | SponsoredNew “Trump” currency proposed in DCA former U.S. Presidential Advisor has come forward with a stern warning to investors: “Get out of tech, no...Paradigm Press | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Tyra Biosciences, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Tyra Biosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.